Heat Stroke

14 registered clinical trials studyying Heat Stroke — 10 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Mechanism Study of G Protein-coupled Receptor 81 in Multiple Organ Dysfunction of Heat Stroke NCT07346443	Second Affiliated Hospital of Wenzhou Medical University	—
Recruiting	Genetic Risk Factor for Heat Stroke NCT06847256	University of Iowa	—
Not Yet Recruiting	Study on the Establishment of a System for Early Warning and Prognostic Evaluation of Patients With Heat Strok NCT05155358	Xijing Hospital	—
Recruiting	Application of an Early In-Hospital Temperature Management Protocol for Heat Stroke Patients NCT06537557	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Use of Sodium Bicarbonate as Prophylaxis for Kidney Damage in Patients With Heatstroke NCT06622525	Hospital General de Mexicali	N/A
Recruiting	Heat Strain Prevention in Elderly Agricultural Workers NCT06192069	Cairo University	N/A
Recruiting	The Relationship Between Normal Saline Infusion and Acute Kidney Injury in Heat Stroke NCT05921695	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Early Body Temperature Targets and Relationship With Prognosis in Patients With Heat Stroke NCT05921682	Second Affiliated Hospital, School of Medicine, Zhejiang University	—
Recruiting	Non-inferiority Study of the Effect of Non-cooling Blanket on Body Temperature in Patients With Heat Stroke NCT05923931	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Study of Thermoregulation in Exercise Heat Stroke in the Military Environment NCT05847465	Direction Centrale du Service de Santé des Armées	—
Unknown	Study of Risk Factors for the Occurrence and Severity of Exertional Heatstroke in the Military Environment NCT04593316	Direction Centrale du Service de Santé des Armées	—
Completed	Heat Emergency Awareness and Treatment (HEAT) NCT03513315	Johns Hopkins University	N/A
Completed	Efficacy and Safety of Ryanodex® (EGL-4104) as Adjuvant Treatment in Subjects With Exertional Heat Stroke (EHS NCT02513095	Eagle Pharmaceuticals, Inc.	Phase 2
Completed	The Development Of A Novel Biomarker For Early Identification Of The Individual's State Of Tolerance To Heat NCT01290159	Sheba Medical Center	—